Novo Nordisk plans summer launches for new diabetes drug
May 7, 2009Research and Development, Sales and Marketing Novo Nordisk, Victoza, diabetes
Novo Nordisk is preparing Victoza for a summer launch into its first European markets, including the UK, after it was …
NHS should be ‘jewel in the crown’ for UK biotech
May 7, 2009Research and Development NICE
The NHS could be the 'jewel in the crown' of UK medical research, if it would only assist in clinical …
Sanofi-Aventis makes 200m euro push into antibodies
May 7, 2009Manufacturing and Production Sanofi-Aventis, biologicals
Sanofi-Aventis will spend 200 million euros to convert one of its facilities near Paris into a biotechnology facility which is …
Building better relations with tomorrow’s doctors
May 6, 2009Sales and Marketing doctors, industry relations
A huge amount of time and money is spent by the pharma industry on interacting with the medical community and …
Bayer launches UK television ads for its morning-after pill
May 6, 2009Sales and Marketing Bayer
Bayer Schering Pharma has launched a television advertising campaign for its morning-after pill Levonelle One Step in the UK. The …
Pharma manufacturing: news in brief
May 6, 2009Manufacturing and Production Pfizer
Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including Pfizer's increased adoption of contract manufacturing and facility …
Ranbaxy woes continue with antibiotic recall
May 6, 2009Sales and Marketing Ranbaxy, US
Indian drugmaker Ranbaxy Laboratories has recalled an antibiotic on sale in the US, suggesting that it still has some way …
Bayer Schering’s contraceptive patch enters phase III
May 5, 2009Research and Development, Sales and Marketing Bayer, sexual health
Bayer Schering is to start phase III trials of its new contraceptive patch and anticipates submitting the product for regulatory …
EDQM takes issue with more Chinese APIs
May 5, 2009Manufacturing and Production Asia, China
The European Directorate on the Quality of Medicines has suspended the certificates of suitability (CEPs) of four active pharmaceutical ingredients …
Coast first casualty in US overhaul of IRB system
May 5, 2009Research and Development FDA, US
A US company offering institutional review board services to sponsors of clinical trials has been forced to close its doors …
Pfizer dips in first quarter
May 1, 2009Sales and Marketing Pfizer
Pfizer saw its performance dip in the first quarter of 2009, with revenue down 8% year-on-year. The company, which is …
Biotech partnering in the credit crunch
May 1, 2009Research and Development biotech, partnering, pharma
Action Pharma’s Torben Jung Laursen explores the new challenges facing pharma-biotech partnering as a result of the economic downturn.In today’s …
BMS turns in solid first quarter results
May 1, 2009Sales and Marketing BMS
Bristol-Myers Squibb turned in respectable figures for the first quarter of 2008, with net income up 5% to $921 million. …
UK’s branded pharma sales predicted to decline
May 1, 2009Sales and Marketing NHS
As part of the UK government's drive to save £2.3 billion in the NHS during 2010-11, £550m will be cut …
Avastin fails in colon cancer study
April 30, 2009Research and Development Cancer, Roche
Roche's blockbuster Avastin has failed to show success in treating early-stage colon cancer. A phase III trial found Avastin (bevacizumab) …
Sanofi makes cuts to phase III pipeline
April 30, 2009Research and Development Sanofi-Aventis
Sanofi-Aventis has suspended development of four late-stage drugs and ten other projects following an R&D review. The decision was announced …
NICE could ease QALY to boost innovation
April 30, 2009Research and Development NICE
NICE could be set to dramatically change its cost-effectiveness measure and help boost innovation in the UK, according to Sir …
Minister thanks pharma for help in swine flu fight
April 30, 2009Research and Development h1n1
Health secretary Alan Johnson kept an appointment to address the ABPI's annual conference yesterday despite the spread of swine flu …
Developing health, developing profits
April 30, 2009Research and Development, Sales and Marketing Pfizer, healthcare, working poor
Pfizer's Dr Ponni Subbiah is at the forefront of a revolution in the way the pharma industry views its business, …
Nexavar fails in melanoma study
April 30, 2009Research and Development Bayer, Cancer, Nexavar
Onyx Pharmaceuticals and its development partner Bayer have stopped a phase II trial of Nexavar in patients with late-stage melanoma, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
Long-acting therapies set to reshape HIV treatment market
